14- NCT043
90,152 Safety and Efficacy of Intravenous Wharton’s
Jelly Derived
Mesenchymal Stem
Cells in Acute
Respiratory Distress
Syndrome due to COVID19 I and II Not Recruiting 40 WJ-MSCs DOS: June 2020
DOC: May 2021 Both 18 to 80 Yrs. Colombia